Thomas E. Zahn


Related Content

  • Duquesne University, School of Law, JD, summa cum laude, Executive Articles Editor, Duquesne Law Review, 2007
  • Carnegie Mellon University, BS, Managerial Economics, 1999
  • Pennsylvania

Member, Pennsylvania Bar Association

Member, Allegheny County Bar Association

Member and Coach, Franklin Area Midget Football Association

Tom focuses his practice on private equity-backed corporate transactions. He regularly represents private equity funds, mezzanine finance funds, family offices and institutional co-investors, independent sponsors, privately held companies and executives in a wide variety of transactional matters, including platform and add-on acquisitions, leveraged buyouts, control, minority, growth and structured equity investments, divestitures, joint ventures, recapitalizations, commercial transactions, executive employment agreements and corporate governance matters.

His transactional experience extends across numerous borders and spans a wide array of industries, including healthcare, energy and infrastructure, education, food and beverage, distribution and manufacturing, consumer products, transportation and technology.

Tom brings a partner approach to client engagements and leverages McGuireWoods’ firm-wide emphasis on matching world-class service and capabilities with an entrepreneurial spirit to deliver tremendous value to his clients. He also regularly acts as outside general counsel for private equity portfolio companies and other private companies that have limited internal legal support resources. Tom leads the Firm’s regional independent sponsor roundtable groups in New York and Pennsylvania.

Prior to practicing law, Tom was a strategic sourcing consultant for a global supply chain company now owned by SAP, where he advised numerous companies on cutting-edge strategies for achieving their corporate purchasing objectives.

"My unique blend of legal and business experience enables me to bring a broad and practical perspective to bear when serving my clients."

In the News

Thomas Zahn
T: +1 412 667 7906F: +1 412 667 7962Tower Two-Sixty
260 Forbes Avenue
Suite 1800
Pittsburgh, PA 15222-3142

Representation of one of the world’s largest independent alternative asset management firms in its $55 million debt and equity investment in two healthcare providers.

Representation of LLR Partners in connection with its purchase of all of the equity interests of Learn-It Systems.

Representation of LLR Partners in its $35 million investment in SDG Holding Company, the parent company of Schweiger Dermatology Group.

Representation of JWI Capital and Squire Ridge Company in their purchase of Allegheny Performance Plastics, LLC from Allegheny Performance Plastics, Inc.

Representation of American Capital, Ltd. in its sale of The Meadows, its portfolio company, to Alita Care, LLC.

Representation of a provider of medical alert and medication dispensing systems in its sale to the largest independent provider of Personal Emergency Response Systems in North America.

Representation of Acacia Partners in its investment in Vision Radiology, a teleradiology medical practice.

Representation of Acacia Partners in its acquisition of Sutherland Perennials Group, a provider of high-quality fabrics, outdoor furniture and interior design products.

Represented a dental supply company in its sale of a majority equity interest to a private equity firm.   

Represented an oil and gas operator in its acquisition of upstream and midstream oil and gas assets from a publicly-traded oil and gas company.

Represented an oil and gas operator in its sale of midstream assets to a supplier and marketer of natural gas, liquid fuels and electricity.

Represented an oil and gas operator in connection with a bridge loan from an investment advisor specializing in direct lending.

Represented a middle market private equity firm in its acquisition of all of the equity interests of an educational services company.

Represented a private equity firm in its acquisition of a company that delivers professional in-home nursing care to qualified beneficiaries.

Represented a Fortune 100 financial services organization  in connection with its financing of a private equity firm’s acquisition of a leading technology-enabled distributor of medical products.

Represented a Pennsylvania-based private equity firm with more than $2 billion across several funds in three notable transactions.

Represented a Chicago-based lower middle-market private equity firm in multiple transactions over the last year including investments in the largest orthodontic dental support organization and a dermatology practice management company and its partner practice.

Represented a private equity backed portfolio company in an add-on acquisition for a provider of medical dermatology and Mohs surgery.

Represented one of the world’s largest independent alternative management firms with over $45 billion of assets under management, in several marquee investments over the last year.

Represented a leading growth-oriented private equity firm in its investment, by way of acquisition, in a global leader in infrastructure operations and maintenance. 

Advised a Texas-based company that formulates, manufactures and markets Aloe vera-based premium, wholesale, natural solutions for grooming and animal care in its sale to a manufacturer and marketer of animal nutrition and care products.

Represented one of the largest providers of medical alert and medication dispensing systems in Kansas, in its sale to one of the largest independent providers of Personal Emergency Response Systems in North America. 

Moderator, "Benefits and Challenges of Partnering with Independent Sponsors from the Viewpoint of a Capital Provider," 2017 Independent Sponsor Conference, October 5, 2017
Moderator, "The Next Wave of Consolidation in PPM Models: Emergency Medicine, Allergy, Opthalmology and What Else is Next?," 14th Annual Healthcare and Life Sciences Private Equity and Finance Conference, February 22, 2017
Moderator, "Healthcare Investing for Historically Non Healthcare Funds (aka – How to Get Smart in Healthcare Investing)," 13th Annual Healthcare and Life Sciences Private Equity and Finance Conference, February 23, 2016